Yutaka Niihara - Jul 29, 2021 Form 4 Insider Report for Emmaus Life Sciences, Inc. (EMMA)

Role
Chairman and CEO, Director, 10%+ Owner
Signature
Yutaka Niihara, M.D., M.P.H.
Stock symbol
EMMA
Transactions as of
Jul 29, 2021
Transactions value $
$6,072
Form type
4
Date filed
8/2/2021, 05:06 PM
Previous filing
Jul 28, 2021
Next filing
Aug 5, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EMMA Common stock, $0.001 par value Purchase $1.5K +1K +0.01% $1.50* 10.8M Jul 29, 2021 Direct F1
transaction EMMA Common stock, $0.001 par value Purchase $750 +500 +0% $1.50* 10.8M Jul 30, 2021 Direct F1
transaction EMMA Common stock, $0.001 par value Purchase $3.82K +2.6K +0.02% $1.47* 10.8M Aug 2, 2021 Direct F1, F2
holding EMMA Common stock, $0.001 par value 92.8K Jul 29, 2021 By Hope International Hospice, Inc. F3
holding EMMA Common stock, $0.001 par value 63K Jul 29, 2021 By Soomi Niihara
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares shown include shares owned jointly with Soomi Niihara, the reporting person's wife.
F2 The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.44 to $1.50, inclusive. The reporting person undertakes to provide to Emmaus Life Sciences, Inc., any security holder of Emmaus Life Sciences, Inc., and the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (2).
F3 Hope International Hospice, Inc, is a California corporation of which Dr. Niihara and his wife are the sole shareholders and directors.